OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Release Date
2022
(2)
2021
(2)
2025
(1)
2019
(1)
2014
(1)
2013
(1)
2011
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Not available
S-EPMC3667971
|
biostudies-literature
Cite
Liver transplantation and cirrhotomimetic hepatocellular carcinoma: classification and outcomes.
Not available
S-EPMC4146426
|
biostudies-literature
Cite
Poor immune response to coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients.
Not available
S-EPMC9595300
|
biostudies-literature
Cite
Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY).
Not available
S-EPMC8826015
|
biostudies-literature
Cite
Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.
Not available
S-EPMC7969418
|
biostudies-literature
Cite
Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study.
Not available
S-EPMC6959970
|
biostudies-literature
Cite
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.
Not available
S-EPMC3736350
|
biostudies-literature
Cite
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Not available
S-EPMC8639765
|
biostudies-literature
Cite
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia.
Not available
S-EPMC11846769
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets